SH3BP2 Antibody, Biotin conjugated

Shipped with Ice Packs
In Stock

Description

Applications

This antibody is optimized for:

  • ELISA: Quantitative detection of SH3BP2 in human biological samples, such as tissue homogenates and body fluids .

  • Western Blotting (WB): Detection of SH3BP2 in lysates from immune cells, osteoclasts, and muscle tissues .

  • Immunoprecipitation (IP): Isolation of SH3BP2 complexes for downstream mass spectrometry or functional studies .

Validation and Quality Control

The antibody undergoes rigorous validation:

  • Specificity: Tested against recombinant SH3BP2 and confirmed to lack cross-reactivity with unrelated proteins .

  • Sensitivity: Detects SH3BP2 at concentrations as low as 0.1–1 ng/mL in ELISA assays .

  • Optimal Dilutions:

    • ELISA: 1:5,000–1:20,000 (starting recommendations) .

    • WB: 1:500–1:2,000 .

Source:

Research Contributions

The SH3BP2 Antibody, Biotin conjugated, has facilitated key discoveries in:

4.1. Cherubism Pathogenesis

Mutations in SH3BP2 cause cherubism, a rare bone disorder characterized by jaw lesions. The antibody was used to confirm that activating mutations stabilize SH3BP2, leading to hyperactive signaling in osteoclasts and excessive bone resorption .

4.2. Neuromuscular Junction Regulation

Studies employing this antibody revealed SH3BP2’s role in acetylcholine receptor (AChR) clustering at neuromuscular junctions. Depletion of SH3BP2 disrupts AChR organization, impairing synaptic transmission .

4.3. Autoimmune Disease Modulation

In lupus-prone mice, a gain-of-function SH3BP2 mutation reduced anti-dsDNA antibody levels and improved survival rates. The antibody was critical for validating SH3BP2 expression in immune cells .

4.4. Promoter Regulation

PARP1 binds to the SH3BP2 promoter, modulating its transcription. The antibody confirmed that PARP1 knockout reduces SH3BP2 expression in bone marrow-derived macrophages .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Typically, we are able to ship products within 1-3 business days after receiving your order. Delivery timelines may vary depending on the purchasing method or location. For specific delivery information, please consult your local distributor.
Synonyms
3BP-2 antibody; 3BP2 antibody; 3BP2_HUMAN antibody; Abl SH3 binding protein 2 antibody; Cherubism antibody; CRBM antibody; CRPM antibody; FLJ42079 antibody; FLJ54978 antibody; RES4-23 antibody; SH3 domain binding protein 2 antibody; SH3 domain-binding protein 2 antibody; Sh3bp2 antibody; TNFAIP3 interacting protein 2 antibody
Target Names
Uniprot No.

Target Background

Function
This antibody binds differentially to the SH3 domains of certain proteins involved in signal transduction pathways. It also binds to phosphatidylinositols, linking the hemopoietic tyrosine kinase fes to the cytoplasmic membrane in a phosphorylation-dependent mechanism.
Gene References Into Functions
  1. All members exhibited a heterozygous missense c.1244G>C; p.Arg415Pro SH3BP2 mutation. PMID: 28721660
  2. The adaptor protein 3BP2 is crucial for KIT receptor expression and the survival of human mast cells. PMID: 25810396
  3. A c.1244G>A (p.Arg415Gln) mutation in the SH3BP2 gene has been associated with cherubism in a Turkish family. PMID: 24608212
  4. Researchers have concluded that a novel p.Asp419Tyr alteration in SH3BP2 is a cherubism-causing mutation in a Turkish family. PMID: 23083484
  5. In the first family, a missense mutation Arg415Gln was identified in exon 9 of SH3BP2 in all affected individuals. The unaffected individuals did not carry this mutation. In the second family, a missense mutation Pro418Thr was identified in exon 9 of the SH3BP2 gene. PMID: 22795151
  6. These findings demonstrate that PARP1 regulates the expression of SH3BP2. PMID: 22820184
  7. The P416R mutation of 3BP2 leads to a gain of function in B cells by increasing its interaction with specific signaling molecules. PMID: 21794028
  8. If a primary genetic defect is the cause of cherubism, it is either located in SH3BP2 gene exons not yet linked to the condition or in a different gene. PMID: 21680150
  9. The SH-3BP-2 mutation may play a role in the differentiation and maturation of osteoclast-like cells in the lesions of cherubism. PMID: 19576004
  10. Overexpression of SH3BP2 in RAW 264.7 cells enhances sRANKL-stimulated phosphorylation of PLCgamma1 and PLCgamma2. PMID: 20872577
  11. No SH3BP2 gene mutation was detected in PGCL. PMID: 20002873
  12. Regulation of FcepsilonRI-mediated degranulation by the adaptor protein 3BP2 in rat basophilic leukemia RBL-2H3 cells has been observed. PMID: 12200378
  13. 3BP2 may regulate B cell receptor-mediated gene activation through Vav proteins. PMID: 15345594
  14. The adaptor protein SH3BP2 regulates transcription factors through its tyrosine phosphorylation and SH2 domain. PMID: 15751964
  15. CD244-3BP2 association regulates cytolytic function but not IFN-gamma release. PMID: 16177062
  16. No mutations were found...in giant cell granuloma. PMID: 16713042
  17. The research delves into how SH3BP2 impacts leukocyte signaling and influences cherubism. PMID: 16802602
  18. A novel A1517G missense mutation at the SH3BP2 gene was identified in a Chinese family with multiple affected individuals with cherubism. PMID: 17147794
  19. Mutations in SH3BP2 have been identified in a rare human disease related to cranial-facial development called cherubism, suggesting a role for 3BP2 in regulating osteoclast and hematopoietic cell function. [REVIEW] PMID: 17156730
  20. An unexpected role for 3BP2 in endocytic and cytoskeletal regulation has been observed through its interaction with CIN85 and HIP-55. PMID: 17306257
  21. A new mutation in a family affected with cherubism has been identified. PMID: 17321449
  22. Individuals with Giant Cell Granuloma of the Jaw do not harbor cherubism-related germline SH3BP2 mutations. PMID: 17544554
  23. Point mutations in the SH3BP2 gene have been reported in cherubism patients. PMID: 18596838
  24. Two novel mutations were found: a heterozygous missense mutation c.1442A>T (Q481L) in exon 11 in one sporadic case of CGCL and a heterozygous germline and tumor tissue missense mutation c.320C>T (T107M) in exon 4 in one patient with cherubism. PMID: 19017279
  25. 3BP2 induces the protein complex with cellular signaling molecules through phosphorylation of Tyr(183) and SH2 domain leading to the activation of NFAT in B cells. PMID: 19833725

Show More

Hide All

Database Links

HGNC: 10825

OMIM: 118400

KEGG: hsa:6452

STRING: 9606.ENSP00000422168

UniGene: Hs.167679

Involvement In Disease
Cherubism (CRBM)
Tissue Specificity
Expressed in a variety of tissues including lung, liver, skeletal muscle, kidney and pancreas.

Q&A

Basic Research Questions

  • What is SH3BP2 and what cellular functions does it regulate?

    SH3BP2 is an adaptor protein primarily expressed in immune cells, including macrophages, B cells, and T cells. It functions by regulating intracellular signaling through interactions with various proteins such as Syk, phospholipase Cγ, Vav, and Src . SH3BP2 plays critical roles in immune cell function and bone metabolism. At the molecular level, it binds differentially to SH3 domains of certain proteins in signal transduction pathways and interacts with phosphatidylinositols, connecting hemopoietic tyrosine kinase fes to the cytoplasmic membrane in a phosphorylation-dependent mechanism . Research has demonstrated SH3BP2's involvement in autoimmune diseases, with both gain-of-function mutations and deficiencies showing modulatory effects on disease progression in lupus models .

  • What is the advantage of using a biotin-conjugated SH3BP2 antibody versus non-conjugated versions?

    Biotin-conjugated antibodies offer several methodological advantages over non-conjugated antibodies. The biotin-streptavidin system provides signal amplification due to the high affinity binding (Kd ≈ 10^-15 M) between biotin and streptavidin, enhancing detection sensitivity—particularly valuable for low-abundance proteins like SH3BP2. In sandwich ELISA applications, the biotin-conjugated SH3BP2 antibody acts as a detection antibody that binds to the target protein already captured by immobilized antibodies . This system allows for flexible detection using streptavidin-conjugated reporter enzymes such as HRP, enabling colorimetric signal development proportional to SH3BP2 concentration . Additionally, biotin-conjugated antibodies facilitate multiplex detection systems and can be used in protocols requiring sequential probing without cross-reactivity concerns.

  • What are the key characteristics of the SH3BP2 Antibody, Biotin conjugated?

    The SH3BP2 Antibody, Biotin conjugated is a polyclonal antibody derived from rabbits with IgG isotype . Its primary application is in ELISA, particularly in sandwich ELISA formats where it serves as the detection antibody following target capture . The antibody demonstrates reactivity with human SH3BP2 and is formulated in liquid form . It recognizes SH3BP2 (also known by alternative names including 3BP2, CRBM, CRPM, RES4-23, and TNFAIP3 interacting protein 2) . The antibody should be stored at -20°C or -80°C according to manufacturer recommendations to maintain optimal activity . Its high specificity for SH3BP2 makes it suitable for sensitive detection without significant cross-reactivity with analogous proteins .

  • How does SH3BP2 function in immune cell signaling pathways?

    SH3BP2 functions as a critical scaffold protein in immune cell signaling through multiple interactions with signaling molecules. In immune cells, SH3BP2 regulates various cellular functions by interacting with key signaling proteins including Syk, phospholipase Cγ, Vav, and Src . These interactions facilitate signal transduction from surface receptors to downstream effectors. SH3BP2 appears to play significant roles in both innate and adaptive immune responses, as evidenced by studies showing its involvement in macrophage, B cell, and T cell function . In the context of autoimmune disease models, SH3BP2 modulates immune responses through several mechanisms. In lupus models, gain-of-function mutation in SH3BP2 ameliorates disease phenotypes by reducing anti-dsDNA antibody titers and autoreactive lymphocytes . Conversely, SH3BP2 deficiency also reduces lupus-like phenotypes, including suppressing autoantibody production (anti-dsDNA antibody and rheumatoid factor), reducing the aberrant accumulation of double-negative T cells, and decreasing T cell activation .

  • What are the main tissues and cell types where SH3BP2 is expressed?

    SH3BP2 demonstrates a predominantly immune cell-specific expression pattern. It is highly expressed in macrophages, B cells, and T cells, making it a critical protein in immune system function . Studies have shown that SH3BP2 is particularly important in myeloid lineage cells, where it plays roles in inflammatory responses and osteoclastogenesis through SYK signaling . Beyond immune cells, research has revealed SH3BP2 expression in neural tissues, particularly at neuromuscular junctions where it interacts with postsynaptic proteins including acetylcholine receptor (AChR) subunits, Low-density lipoprotein 4 (Lrp4), and components of the dystroglycan complex . When designing experiments targeting SH3BP2, researchers should consider these tissue expression patterns to select appropriate models and controls, particularly when exploring SH3BP2 function in autoimmune conditions, bone metabolism disorders, or neuromuscular junction development.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.